Skip to search formSkip to main contentSkip to account menu

Reversible Inhibitors of Monoamine Oxidase

Known as: Reversible Inhibitor of Monoamine Oxidase 
RIMA shows preference for the A isoenzyme
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Monoamine Oxidase Inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Rhesus monkey cerebrospinal fluid amine metabolite changes following treatment with the reversible monoamine oxidase type-A inhibitor cimoxatone
The effects of cimoxatone, a reversible inhibitor of monoamine oxidase type A (MAO-A), on the deaminated metabolites of… 
2003
2003
Mapping the Cerebral Monoamine Oxidase Type A: Positron Emission Tomography Characterization of the Reversible Selective Inhibitor [11C]Befloxatone
Befloxatone is a competitive and reversible inhibitor of monoamine oxidase-A (MAOI-A). The aim of the study was to characterize… 
2001
2001
Patient compliance with enteric-coated weekly fluoxetine during continuation treatment of major depressive disorder.
Background: A once-weekly enteric-coated formulation of fluoxetine represents a new, effective option for the long-term treatment… 
2000
2000
Focal cerebral ischemia-induced escape deficit in rats is ameliorated by a reversible inhibitor of monoamine oxidase-a: implications for a novel animal model of post-stroke depression.
The present investigation was conducted to examine whether a reversible inhibitor of monoamine oxidase (MAO)-A, T-794, affects… 
Review
1998
Review
1998
Clinical pharmacology of befloxatone: a brief review.
1997
1997
Pharmacology of the new reversible inhibitor of monoamine oxidase A, RS‐8359
RS-8359 is a new reversible inhibitor of monoamine oxidase A (RIMA). With a selectivity ratio of about 2200 for (ho: A:B enzyme… 
1992
1992
Monoamine Oxidase Inhibitors (MAOI) or Reversible Inhibitors of Monoamine Oxidase (RIMA)/Tricyclic Antidepressant (TCA) Combination Therapy
The combination of TCA and MAOI began in the 1960s for some patients who did not seem responsive to either class of… 
1985
1985
The effects of amiflamine on cerebrospinal fluid amine metabolites in the rhesus monkey.
1983
1983
Studies on amiflamine, a reversible inhibitor of monoamine oxidase type A, selective for serotonergic neurons.
Studies on amiflamine, a reversible inhibitor of monoamine oxidase type A, selective for serotonergic neurons 
1959
1959
The pharmacological evaluation of monoamine oxidase inhibitors.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)